| Subject: | New Laboratory Test To Detect Human Infections With Avian Influenza A/H5 Viruses |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 7 Feb 2006 - 10:00 am |
| The FDA has announced the approval of a new laboratory test, developed by the CDC, to diagnose H5 strains of influenza in patients suspected to be infected with the virus.
The lab test is called Influenza A/H5 (Asian lineage) Virus Real-time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Primer and Probe Set. The test provides preliminary results on suspected H5 influenza samples within four hours once a sample arrives at the lab and testing begins. Previous testing technology would... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCES:
Policies / Forms / Additional Resources:
Additional Tools Related to This Topic:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
